GeneTex

  • Country / Location Selection

United States (US)

Tafazzin / TAZ antibody, N-term

Anti-Tafazzin / TAZ antibody, N-term used in Western Blot (WB). GTX81015
Anti-Tafazzin / TAZ antibody, N-term used in Western Blot (WB). GTX81015
Anti-Tafazzin / TAZ antibody, N-term used in IHC (Paraffin sections) (IHC-P). GTX81015
Anti-Tafazzin / TAZ antibody, N-term used in Flow cytometry (FACS). GTX81015

Cat. No. GTX81015

Host

 Rabbit

Clonality

 Polyclonal

Isotype

 IgG

Application

 WB, IHC-P, FACS

Reactivity

 Human
Package
400 μl ($399)
See all Tafazzin / TAZ products

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
WB 1:1000
IHC-P 1:50-1:100
FACS 1:10-1:50
Not tested in other applications.

Calculated MW

33 kDa. ( Note )

PROPERTIES

Form

Liquid

Buffer

PBS

Preservative

0.09% Sodium azide

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

Batch dependent (Please refer to the vial label for the specific concentration.)

Antigen Species

Human

Immunogen

KLH conjugated synthetic peptide between 32-60 amino acids from the N-terminal region of human Tafazzin / TAZ.

Purification

Protein A purified, followed by peptide affinity purification.

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

tafazzin , BTHS , CMD3A , EFE , EFE2 , G4.5 , LVNCX , Taz1

Background

This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]

Database

Research Area

DATA IMAGES

Anti-Tafazzin / TAZ antibody, N-term used in Western Blot (WB). GTX81015

GTX81015 WB Image

WB analysis of MDA-MB231 and NCI-H460 cell lysate (35ug/lane) using GTX81015 TAZ antibody, N-term.

Anti-Tafazzin / TAZ antibody, N-term used in Western Blot (WB). GTX81015

GTX81015 WB Image

WB analysis of MCF-7 and NCI-H460 cell using GTX81015 TAZ antibody, N-term.
Loading : 20ug per lane
Dilution : 1:1000

Anti-Tafazzin / TAZ antibody, N-term used in IHC (Paraffin sections) (IHC-P). GTX81015

GTX81015 IHC-P Image

IHC-P analysis of human skeletal muscle using GTX81015 TAZ antibody, N-term.

Anti-Tafazzin / TAZ antibody, N-term used in Flow cytometry (FACS). GTX81015

GTX81015 FACS Image

FACS analysis of MDA-MB231 cells using GTX81015 TAZ antibody, N-term.
Green : primary antibody
Blue : negative control

REFERENCE

There are currently no references for Tafazzin / TAZ antibody, N-term (GTX81015). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for Tafazzin / TAZ antibody, N-term (GTX81015). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 399